Drugs Mentioned in This Article
Amphetamine (Adderall)
Bupropion (Wellbutrin)
Clozapine (Clozaril)
Felbamate (Felbatol)
Haloperidol (Haldol)
Lithium (Eskalith)
Olanzapine (Zyprexa)
Risperidone (Risperdal)
Topiramate (Topamax)
Zonisamide (Zonegran)
Evidence-Based References
- Britz B, Siegfried W, Ziegler A, et al. Rates of psychiatric disorders in a clinical study group of adolescents with extreme obesity and in obese adolescents ascertained via a population based study. Int J Obes Relat Metab Disord. 2000;24:1707-1714.
- Epstein LH, Myers MD, Raynor HA, Saelens BE. Treatment of pediatric obesity. Pediatrics. 1998;101: 554-570.
References
1. Barlow SE, Trowbridge FL, Klish WJ, Dietz WH. Treatment of child and adolescent obesity: reports from pediatricians, pediatric nurse practitioners, and registered dietitians. Pediatrics. 2002;110:229-235.
2. Fitzgibbon M. Commentary on psychiatric aspects of child and adolescent obesity: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 2004;43: 151-153.
3. Zametkin AJ, Zoon CK, Klein HW, Munson S. Psychiatric aspects of child and adolescent obesity: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 2004;43:134-150.
4. Barlow SE, Dietz WH. Obesity evaluations and treatment: expert committee recommendations: the Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics. 1998;102:E29.
5. National Center for Health Statistics. Prevalence of Overweight Among Children and Adolescents: United States, 1999. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/
overwght99.htm. Accessed August 1, 2006.
6. Goodman E, Whitaker RC. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics. 2002;110: 497-504.
7. Ogden CL, Flegal KM, Carroll MD, Jonson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288: 1728-1732.
8. Pesa JA, Syre TS, Jones E. Psychosocial differences associated with body weight among female adolescents: the importance of body image. J Adolesc Health. 2000;26:330-337.
9. Pine DS, Cohen P, Brook J, Coplan JD. Psychiatric symptoms in adolescence as predictors of obesity in early adulthood: a longitudinal study. Am J Public Health. 1997;87:1303-1310.
10. Neumark-Sztainer D, Story M, French SA, et al. Psychosocial concerns and health compromising behaviors among overweight and nonoverweight adolescents. Obes Res. 1997;5:237-249.
11. Britz B, Siegfried W, Ziegler A, et al. Rates of psychiatric disorders in a clinical study group of adolescents with extreme obesity and in obese adolescents ascertained via a population based study. Int J Obes Relat Metab Disord. 2000;24:1707-1714.
12. Rumpel C, Harris TB. The influence of weight on adolescent self-esteem. J Psychom Res. 1994;38: 547-556.
13. Kawachi I. Physical and psychological consequences of weight gain. J Clin Psychiatry. 1999;60(suppl 21): 5-9.
14. French SA, Story M, Perry CL. Self-esteem and obesity in children and adolescents: a literature review. Obes Res. 1995;3:479-490.
15. Moore LL, Lombardi DA, White MJ, et al. Influence of parents' physical activity levels on activity levels of young children. J Pediatr. 1991;118:215-219.
16. Rand CS, Macgregor AM. Adolescents having obesity surgery: a 6-year follow-up. South Med J. 1994;87: 1208-1213.
17. Epstein LH, Myers MD, Raynor HA, Saelens BE. Treatment of pediatric obesity. Pediatrics. 1998;101: 554-570.
18. Jelalian E, Saelens BE. Empirically supported treatments on pediatric psychology: pediatric obesity. J Pediatr Psychol. 1999;24:223-248.
19. Masand P. Weight gain with psychotropics: size does matter. J Clin Psychiatry. 1999;60(suppl 20):3-4.
20. Horrigan JP, Barnhill LJ, Kohli RR. Adderall, the atypicals, and weight gain. J Am Acad Child Adolesc Psychiatry. 2001;40:620.
21. Gothelf D, Falk B, Singer P, et al. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry. 2002;159: 1055-1057.
22. Sachs GS, Guille C. Weight gain associated with use of psychotropic medications. J Clin Psychiatry. 1999;60 (suppl 21):16-19.